SCHEMBL5265708

SCHEMBL5265708

O=C1CC=NC(c2ccccc2)=N1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 2/20 0.34
GOPC Q9HD26 2/20 0.34
ALDH1A1 P00352 5/20 0.33
KMT2A Q03164 3/20 0.33
MAPT P10636 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
KDM4E B2RXH2 2/20 0.33
GAA P10253 2/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
GFER P55789 1/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
NOTUM Q6P988 1/20 0.33
AXL P30530 1/20 0.32
USP1 O94782 1/20 0.32
USP19 O94966 1/20 0.32
WDR48 Q8TAF3 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL643335 0.68 MAPT (0.37) CFTRGOPCALDH1A1KMT2AMAPT
SCHEMBL3662833 0.66 NOTUM (0.39) ALDH1A1KMT2ASMN1; SMN2GAANPC1
SCHEMBL21151453 0.64 ALDH1A1 (0.53) ALDH1A1KMT2AMAPTSMN1; SMN2HSD17B10
SCHEMBL9369948 0.64 CFTR (0.34) CFTRGOPCALDH1A1KMT2AMAPT
SCHEMBL1199564 0.64
SCHEMBL2522098 0.63
SCHEMBL11316228 0.63 NISCH (0.36) ALDH1A1KMT2AGAANPC1RAB9A
SCHEMBL4633787 0.61 MAPT (0.44) CFTRGOPCALDH1A1KMT2AMAPT
SCHEMBL3056752 0.61 MAPT (0.39) CFTRGOPCALDH1A1KMT2AMAPT
SCHEMBL8656886 0.61 MAPT (0.40) CFTRGOPCALDH1A1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1794135-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-06-13 EP disclosed
WO-2006037117-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2006-04-06 WO disclosed